Participation of adolescents with cancer in clinical trials

Cancer Treatment Reviews

Volumn 33, Issue 7, 2007, Pages 603-608

  Ferrari, Andrea ^a   Bleyer, Archie ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b ST CHARLES MEDICAL CENTER   (United States)

Author keywords

Adolescents with cancer; Clinical trials; Young adults with cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGE; AWARENESS; CANCER CENTER; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURGERY; CANCER SURVIVAL; CHILD HEALTH CARE; CHILDHOOD CANCER; CLINICAL PROTOCOL; CLINICAL TRIAL; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HEALTH CARE NEED; HEALTH CARE SYSTEM; HEALTH PRACTITIONER; HUMAN; INFORMATION DISSEMINATION; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; ONCOLOGY; PATIENT ATTITUDE; PATIENT PARTICIPATION; PATIENT SELECTION; PHYSICIAN ATTITUDE; PROGNOSIS; RESEARCH SUBJECT; REVIEW; SOCIAL PSYCHOLOGY; STAFF TRAINING; TREATMENT OUTCOME;

ADOLESCENT; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PREVALENCE; PROGNOSIS; SURVIVAL RATE;

EID: 34249330009     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2006.11.005     Document Type: Review

References (39)

1. Peppercorn J.M., Weeks J.C., Cook E.F., and Joffe S. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 363 9405 (2004) 263-270
2. Kumar A., Soares H., Wells R., Clarke M., Hozo I., Bleyer A., et al. Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group. BMJ 331 (2005) 1295-1301
3. Meadows A.T., Kramer S., Hopson R., et al. Survival in childhood acute lymphocytic leukemia. Effect of protocol and place of treatment. Cancer Invest (1983) 49-55
4. Wagner H.P., Dingeldein-Bettler I., Berchthold W., et al. Childhood NHL in Switzerland: Incidence and survival in 120 study and 42 non-study patients for the Swiss Pediatric Oncology Group (SPOG). Med Pediatr Oncol 24 (1995) 281-286
5. Lennox E.L., Stiller C.A., Morris-Jones P.H., and Wilson-Kinnier L.M. Nephroblastoma: Treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial. BMJ 2 (1979) 567-569
6. Duffner K., Cohen M.E., and Flannery J.T. Referral patterns of childhood brain tumors in the state of Connecticut. Cancer 50 (1982) 1636-1640
7. Nachman J., Sather H.N., Buckley J.D., et al. Young adults 16-21 years of age at diagnosis entered onto Children's Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment. Cancer 71 10 Suppl (1993) 3377-3385
8. Bleyer A., Budd T., and Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer 107 S7 (2006) 1645-1655
9. Bleyer A, Barr R. Highlights and challenges. In: Bleyer A, O'Leary M, Barr R, Ries LAG, editors. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD 2006.
10. Bleyer A, Budd T, Montello M. Older adolescents and young adults with cancer and clinical trials: lack of participation and progress in North America. In: Bleyer A, Barr R, Albritton K, Phillips M, Siegel S, editors. Cancer in older adolescents and young adults, Springer Verlag, Heidelburg, in press.
11. Liu L., Krailo M., Reaman G.H., and Bernstein L. Childhood cancer patients' access to cooperative group cancer programs: a population-based study. Cancer 97 5 (2003) 1339-1345
12. Bleyer A., Montello M., Budd T., and Saxman S. National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation. Cancer 103 (2005) 1891-1897
13. Bleyer A., Morgan S., and Barr R. Proceedings of a workshop: bridging the gap in care and addressing participation in clinical trials. Cancer 107 7 Suppl (2006) 1656-1658
14. Bleyer W.A. Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol 38 1 (2002) 1-10
15. Stiller C.A., Desandes E., Danon S.E., et al. Cancer incidence and survival in European adolescents (1978-1997). Report from the automated childhood cancer information system project. Eur J Cancer 42 13 (2006) 2006-2018
16. Albritton K., and Bleyer W.A. The management of cancer in the older adolescents. Eur J Cancer 39 18 (2003) 2584-2599
17. Barr R.D. On cancer control and the adolescent. Med Pediatr Oncol 32 (1999) 404-410
18. Joshi D., Anderson J.R., Paidas C., et al. Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer 42 1 (2004) 64-73
19. Ferrari A., Dileo P., Casanova M., et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 98 3 (2003) 571-580
20. Andersen B.L., and Cacioppo J.T. Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. Br J Psychol 34 Pt1 (1995) 33-52
21. Pollock B.H., Krischer J.P., and Vietti T.J. Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr 119 5 (1991) 725-732
22. Haimi M., Peretz Nahum M., and Ben Arush M.W. Delay in diagnosis of children with cancer: a retrospective study of 315 children. Pediatr Hematol Oncol 21 1 (2004) 37-48
23. Ziv A., Boulet J.R., and Slap G.B. Utilization of physician offices by adolescents in the United states. Pediatrics 104 (1999) 35-42
24. Albritton K, Ferrari A, Casanova M. Soft tissue sarcomas. In: Bleyer A, Barr R, Albritton K, Phillips M, Siegel S, editors. Cancer in older adolescents and young adults, Springer Verlag, Heidelburg, in press.
25. Ferrari A., Gtronchi A., Casanova M., et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 101 3 (2004) 627-634
26. Klein-Geltink J., Shaw A.K., Morrison H.I., et al. Use of paediatric versus adult oncology treatment centres by adolescents 15-19 years old: the Canadian Childhood Cancer Surveillance and Control Program. Eur J Cancer 41 3 (2005) 404-410
27. Rauck A.M., Fremgen A.M., Hutchinson C.L., et al. Adolescents cancers in the United States: a national cancer data base (NCDB) report. J Pediatr Hematol Oncol 21 (1999) 310
28. Stock W., Sather H., Dodge R.K., Bloomfield C.D., Larson A., and Nachman J. Outcome of adolescents and young adults with ALL: a comparison of children's cancer group and cancer and leukemia group B regimens. Blood 96 (2000) 467a (Abstract)
29. Boissel N., Auclerc M.F., Lheritier V., et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 21 (2003) 774-780
30. de Bont J.M., van der Holt B., Dekker A.W., et al. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric versus adult ALL protocols in the Netherlands. Leukemia 18 (2004) 2032-2053
31. Ramanujachar R, Richards S, Hann I, Goldstone A, Mitchell C, Vora A, etal. Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer, January 18, 2006; [Epub ahead of print] DOI:10.1002/pbc.20749.
32. Ramanujachar R., Richards S., Hann I., and Webb D. Adolescents with acute lymphoblastic leukaemia: emerging from the shadow of paediatric and adult treatment protocols. Pediatr Blood Cancer 43 6 (2006) 748-756
33. Testi A. Difference in outcome of adolescents (14-17 years) with acute lymphoblastic leukaemia (ALL) enrolled in the Italian pediatric (AIEOP) an adult (GIMEMA) multicenter treatment protocols. Am Society Clin Oncol Proc, J Clin Oncol 24 18S (2006) no. 9024 (Abstract)
34. Paulussen S., Ahrens S., and Juergens H.F. Cure rates in Ewing tumor patients aged over 15 years are better in pediatric oncology units. Results of GPOH CESS/EICESS studies. Proc Am Soc Clin Oncol 22 (2003) 816
35. Spreafico F., Massimino M., Gandola L., et al. Survival of adults treated for medulloblastoma using paediatric protocols. Eur J Cancer 41 9 (2005) 1304-1310
36. Terenziani M., Spreafico F., Collini P., et al. Adult Wilms' tumor: A monoinstitutional experience and a review of the literature. Cancer 101 2 (2004) 289-293
37. Leonard R.C., Gregor A., Coleman R.E., and Lewis I. Strategy needed for adolescent patients with cancer. BMJ 311 7001 (1995) 387
38. Lewis I.J., Fallon S., van Dongen-Melman J., and Barr R. Cancer and the adolescent: the second teenage cancer trust international conference, royal college of physicians, London, England, March 2001. Med Pediatr Oncol 39 3 (2002) 198-201
39. Lewis I.J. Cancer in adolescence. Br Med Bull 52 4 (1996) 887-897